Breaking News Instant updates and real-time market news.

2023-01-23 08:12:35 NCNA NuCana $1.46 / + (+0.00%) 08:12 01/23/23 01/23 08:12 01/23/23 08:12	NuCana regains compliance with Nasdaq minimum bid price requirement NuCana announced that it has received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market informing the Company that it has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5450(a)(1) and the matter is closed.

2023-01-23 08:12:35

NCNA

NuCana

$1.46 / + (+0.00%)

08:12

01/23/23

01/23

08:12

01/23/23

08:12

NuCana regains compliance with Nasdaq minimum bid price requirement

NuCana announced that it has received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market informing the Company that it has regained compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5450(a)(1) and the matter is closed.

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Praxis Precision price target raised to $16 from $10 at H.C. Wainwright » 06:12 02/03/23 02/03 06:12 02/03/23 06:12 PRAX Praxis Precision Medicines $4.78 / -0.12 (-2.45%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PRAX Praxis Precision Medicines $4.78 / -0.12 (-2.45%) 12/13/22 Praxis in strategic epilepsy pact with UCB for up to $100M potential 11/28/22 Praxis to advance PRAX-562 Phase 2 study in pediatric patients 09/20/22 Invitae's Ciitizen data utilized in Praxis' PRAX-222 IND filing 09/20/22 Invitae's citizen data used in Praxis Precision Medicines' PRAX-222 IND filing PRAX Praxis Precision Medicines $4.78 / -0.12 (-2.45%) 06/07/22 Piper Sandler Praxis Precision Medicines price target lowered to $18 from $65 at Piper Sandler 06/07/22 BofA Praxis Precision Medicines downgraded to Neutral from Buy at BofA 06/07/22 H.C. Wainwright Praxis Precision price target lowered to $10 from $48 at H.C. Wainwright 06/06/22 Wedbush Wedbush downgrades Praxis to Neutral, slashes target after ARIA trial failure PRAX Praxis Precision Medicines $4.78 / -0.12 (-2.45%) 11/09/22 Praxis Precision Med reports Q3 EPS (96c), consensus (89c)
Earnings	Avantor reports Q4 adjusted EPS 32c, consensus 30c » 06:12 02/03/23 02/03 06:12 02/03/23 06:12 AVTR Avantor $24.90 / +0.455 (+1.86%) Reports Q4 revenue $1.8B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AVTR Avantor $24.90 / +0.455 (+1.86%) 01/09/23 Avantor, Catalent enter multi-year supply agreement 12/19/22 MamaMancini's appoints Henson to board of directors 09/13/22 Avantor says 'continues to perform well across end markets' 08/15/22 Third Point adds Disney, exits Intuit in Q2 AVTR Avantor $24.90 / +0.455 (+1.86%) 01/24/23 Barclays Avantor price target raised to $26 from $23 at Barclays 12/13/22 Deutsche Bank Avantor initiated with a Hold at Deutsche Bank 10/31/22 Citi Avantor price target lowered to $25 from $28 at Citi 10/31/22 Baird Avantor price target lowered to $29 from $32 at Baird AVTR Avantor $24.90 / +0.455 (+1.86%) 10/28/22 Avantor reports Q3 adjusted EPS 34c, consensus 33c 09/13/22 Avantor sees Q3 revenue $1.84B-$1.85B, consensus $1.91B AVTR Avantor $24.90 / +0.455 (+1.86%) 12/17/22 Buy/Sell: Wall Street's top 10 stock calls this week 10/05/22 Fly Intel: Pre-market Movers 09/13/22 What You Missed On Wall Street On Tuesday 09/13/22 What You Missed On Wall Street This Morning 08:00 Today Avantor - AVTR
Recommendations	Akerna price target lowered to $1 from $1.50 at H.C. Wainwright » 06:11 02/03/23 02/03 06:11 02/03/23 06:11 KERN Akerna $1.12 / +0.005 (+0.45%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly KERN Akerna $1.12 / +0.005 (+0.45%) 02/01/23 Akerna regains compliance with NASDAQ continued listing requirement 01/27/23 Akerna Corp trading resumes 01/27/23 Akerna to resume trading at 9:50 a.m. ET 01/27/23 Akerna to merge with Gryphon, sell software business to POSaBIT KERN Akerna $1.12 / +0.005 (+0.45%) 08/25/22 H.C. Wainwright Akerna downgraded to Neutral from Buy at H.C. Wainwright 05/11/22 Alliance Global Partners Akerna downgraded to Neutral from Buy at Alliance Global Partners 05/11/22 H.C. Wainwright Akerna price target lowered to $1.50 from $2.50 at H.C. Wainwright 03/22/22 Lake Street Akerna downgraded to Hold from Buy at Lake Street KERN Akerna $1.12 / +0.005 (+0.45%) 01/27/23 Here's What You Missed in Crypto This Week 01/12/23 Here's What You Missed in Cannabis This Week 08/25/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Syndicate	Cellectis 8.8M share Spot Secondary priced at $2.50 » 06:11 02/03/23 02/03 06:11 02/03/23 06:11 CLLS Cellectis $3.20 / +0.075 (+2.40%) Jefferies and Barclays… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly CLLS Cellectis $3.20 / +0.075 (+2.40%) 01/17/23 Cellectis announces Calyxt, Cibus sign definitive merger agreement 12/29/22 Cellectis, Primera Therapeutics to partner on gene editing platform 12/28/22 Cellectis enters into EUR 40M credit facility with EIB 12/13/22 Cellectis announces preliminary data for UCART22, UCART123 CLLS Cellectis $3.20 / +0.075 (+2.40%) 01/19/23 JMP Securities Cellectis price target lowered to $6 from $11 at JMP Securities 12/14/22 Citi Cellectis price target lowered to $24 from $36 at Citi 08/18/22 Citi Cellectis price target raised to $36 from $34 at Citi 05/18/22 Baird Cellectis upgraded to Outperform at Baird on valuation 'backstop' CLLS Cellectis $3.20 / +0.075 (+2.40%) 11/03/22 Cellectis reports Q3 EPS (63c), consensus (45c) 08/04/22 Cellectis reports Q2 EPS (88c), consensus (56c) 03 Feb CLLS Cellectis $3.20 / +0.075 (+2.40%) 01/12/23 Biotech Alert: Searches spiking for these stocks today 12/29/22 Fly Intel: After-Hours Movers
Recommendations	Microchip price target raised to $100 from $80 at Piper Sandler » 06:11 02/03/23 02/03 06:11 02/03/23 06:11 MCHP Microchip $84.56 / +3.34 (+4.11%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MCHP Microchip $84.56 / +3.34 (+4.11%) 02/02/23 Microchip sees FY23 capital expenditures $525M-$545M 02/02/23 Microchip boosts dividend 41.5% to 35.8c per share 01/19/23 Microchip announces hybrid power drive module 01/17/23 Microchip launches first COTS rad-tolerant power device MCHP Microchip $84.56 / +3.34 (+4.11%) 01/18/23 Citi Citi opens 'positive catalyst watch' on Microchip and ON Semiconductor 11/29/22 Stifel Microchip price target raised to $80 from $77 at Stifel 11/15/22 Credit Suisse Microchip initiated with a Neutral at Credit Suisse 11/04/22 UBS Microchip price target lowered to $90 from $100 at UBS MCHP Microchip $84.56 / +3.34 (+4.11%) 02/02/23 Microchip sees Q4 EPS $1.61- $1.63, consensus $1.58 02/02/23 Microchip reports Q3 EPS $1.56, consensus $1.55 02/02/23 Notable companies reporting after market close 11/28/22 Microchip back Q3 EPS view $1.54-$1.56, consensus $1.58 MCHP Microchip $84.56 / +3.34 (+4.11%) 01/04/23 China pauses chip industry investments as COVID resurges, Bloomberg reports 12/13/22 China files WTO complaint targeting prior U.S. chip sanctions, FT reports 10/06/22 Restrictions on China chipmakers won't target SK Hynix and Samsung, Reuters says 08/10/22 Chip makers now expect demand slowdown beyond PCs, WSJ reports MCHP Microchip $84.56 / +3.34 (+4.11%) 02/02/23 Fly Intel: After-Hours Movers 01/04/23 What You Missed On Wall Street On Wednesday 01/04/23 What You Missed On Wall Street This Morning 11/03/22 Fly Intel: After-Hours Movers MCHP Microchip $84.56 / +3.34 (+4.11%) 01/24/23 Microchip put volume heavy and directionally bearish 01/23/23 Microchip put volume heavy and directionally bearish 01/05/23 Microchip put volume heavy and directionally bearish 11/16/22 Microchip put volume heavy and directionally bearish
Earnings	Aon plc reports Q4 adjusted EPS $3.89, consensus $3.65 » 06:10 02/03/23 02/03 06:10 02/03/23 06:10 AON Aon plc $322.90 / +3.875 (+1.21%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AON Aon plc $322.90 / +3.875 (+1.21%) 11/10/22 Aon acquires risk assessment modeling firm ERN, terms not disclosed 08/09/22 Aon plc names Mindy Simon as COO, James Platt as Chief Digital Officer AON Aon plc $322.90 / +3.875 (+1.21%) 01/19/23 BMO Capital Aon plc initiated with a Market Perform at BMO Capital 01/13/23 Credit Suisse Aon plc initiated with an Outperform at Credit Suisse 01/10/23 Evercore ISI Aon plc upgraded to In Line at Evercore ISI on discounted valuation 01/10/23 Evercore ISI Aon plc upgraded to In Line from Underperform at Evercore ISI AON Aon plc $322.90 / +3.875 (+1.21%) 10/28/22 Aon plc reports Q3 adjusted EPS $2.02, consensus $1.99 AON Aon plc $322.90 / +3.875 (+1.21%) 09/14/22 Aon plc chosen by QBE for $1B U.S. casualty deal, Insurance Insider says AON Aon plc $322.90 / +3.875 (+1.21%) 10/28/22 Fly Intel: Pre-market Movers 09/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08:30 Today Aon plc - AON AON Aon plc $322.90 / +3.875 (+1.21%) 09/23/22 Early notable gainers among liquid option names on September 23rd
Recommendations	2U price target raised to $10 from $7 at Piper Sandler » 06:10 02/03/23 02/03 06:10 02/03/23 06:10 TWOU 2U $9.88 / +0.67 (+7.28%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TWOU 2U $9.88 / +0.67 (+7.28%) 10/12/22 Google Cloud, edX partner to launch cloud computing professional certificate TWOU 2U $9.88 / +0.67 (+7.28%) 11/21/22 Credit Suisse 2U initiated with a Neutral at Credit Suisse 11/08/22 Barrington 2U price target lowered to $9 from $10 at Barrington 11/08/22 Baird 2U price target lowered to $10 from $14 at Baird 11/08/22 Piper Sandler 2U upgraded to Neutral from Underweight at Piper Sandler TWOU 2U $9.88 / +0.67 (+7.28%) 02/02/23 2U reports Q4 adjusted EPS 23c vs 20c last year 11/07/22 2U reaffirms FY22 revenue view $960M, consensus $962.43M 11/07/22 2U reports Q3 EPS (5c), consensus (3c) TWOU 2U $9.88 / +0.67 (+7.28%) 02/02/23 Fly Intel: After-Hours Movers 11/08/22 What You Missed On Wall Street This Morning
Recommendations	Atlassian price target raised to $160 from $140 at Piper Sandler » 06:09 02/03/23 02/03 06:09 02/03/23 06:09 TEAM Atlassian $182.55 / +12.3 (+7.22%) Piper Sandler analyst Rob… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options TEAM Atlassian $182.55 / +12.3 (+7.22%) 02/02/23 Atlassian board authorized program to repurchase up to $1B of stock 02/01/23 ZoomInfo appoints Ali Dasdan as CTO, Dave Justice as chief revenue officer 11/14/22 Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3 11/14/22 Lone Pine adds Autodesk stake, reduces Meta Platforms, Microsoft stakes TEAM Atlassian $182.55 / +12.3 (+7.22%) 01/30/23 Barclays Zoom Video raising prices for Zoom One Pro, says Barclays 01/19/23 Jefferies Atlassian price target raised to $180 from $150 at Jefferies 01/11/23 Mizuho Atlassian significantly raised prices yesterday, says Mizuho 01/05/23 Jefferies Atlassian upgraded to Buy from Hold at Jefferies TEAM Atlassian $182.55 / +12.3 (+7.22%) 02/02/23 Atlassian sees Q3 revenue $890M-$910M, consensus $900.92M 02/02/23 Atlassian sees FY23 revenue growth y/y 25%, consensus $3.49B 02/02/23 Atlassian reports Q2 adjusted EPS 45c, consensus 31c 11/03/22 Atlassian sees Q2 revenue $835M-$855M, consensus $879.24M TEAM Atlassian $182.55 / +12.3 (+7.22%) 02/02/23 Fly Intel: After-Hours Movers 01/05/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/04/22 What You Missed On Wall Street On Friday 03/06/23 Technology Conference TEAM Atlassian $182.55 / +12.3 (+7.22%) 02/02/23 Atlassian options imply 10.2% move in share price post-earnings 01/19/23 Atlassian call volume above normal and directionally bullish 11/03/22 Atlassian options imply 10.0% move in share price post-earnings 09/22/22 Atlassian call volume above normal and directionally bullish
Earnings	ArcBest reports Q4 EPS $2.45, consensus $2.53 » 06:08 02/03/23 02/03 06:08 02/03/23 06:08 ARCB ArcBest $90.20 / +2.33 (+2.65%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events ARCB ArcBest $90.20 / +2.33 (+2.65%) 11/02/22 Credit Suisse ArcBest price target raised to $92 from $87 at Credit Suisse 10/11/22 Credit Suisse ArcBest price target lowered to $87 from $105 at Credit Suisse 10/07/22 Citi ArcBest price target lowered to $90 from $94 at Citi 09/09/22 Credit Suisse ArcBest price target lowered to $105 from $112 at Credit Suisse ARCB ArcBest $90.20 / +2.33 (+2.65%) 11/01/22 ArcBest reports Q3 EPS $3.80, consensus $3.72 09:30 Today ArcBest - ARCB
Recommendations	Apple optimistic about strength going forward, says Piper Sandler » 06:07 02/03/23 02/03 06:07 02/03/23 06:07 AAPL Apple $150.85 / +5.41 (+3.72%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $150.85 / +5.41 (+3.72%) 02/02/23 Apple pares decline during Q1 conference call, now down 1% at $149.35 afterhours 02/02/23 Apple CFO says 'doing a lot of work on cost structure' to help gross margin 02/02/23 Apple CFO says y/y performance of Q2 to be similar to Q1 02/02/23 Apple CFO Maestri says customer satisfaction for iPhone 14 at 98% AAPL Apple $150.85 / +5.41 (+3.72%) 02/02/23 Lynx Apple price target cut to 'Street low' $110 at Lynx 02/02/23 Barclays SiTime price target raised to $135 from $120 at Barclays 02/01/23 Benchmark Benchmark downgrades 'too far behind' Snap to Hold after earnings 01/31/23 UBS Apple iPhone sell-through down 12% in Q4, says UBS AAPL Apple $150.85 / +5.41 (+3.72%) 02/02/23 Apple reports Q1 EPS $1.88, consensus $1.94 02/02/23 Notable companies reporting after market close 10/27/22 Apple reports Q4 EPS $1.29, consensus $1.17 10/27/22 Notable companies reporting after market close AAPL Apple $150.85 / +5.41 (+3.72%) 02/02/23 Apple CEO cites manufacturing challenges, economy in WSJ interview 02/02/23 Apple to drop design chief role when Hankey departs, Bloomberg reports 02/02/23 Apple eliminating design chief role when Hankey departs, Bloomberg says 02/02/23 Democratic senator joins calls to ban TikTok, WSJ reports AAPL Apple $150.85 / +5.41 (+3.72%) 02/02/23 Fly Intel: After-Hours Movers 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What Wall Street is saying about Apple ahead of earnings 02/02/23 What You Missed On Wall Street This Morning 03/10/23 Apple, Inc. AAPL Apple $150.85 / +5.41 (+3.72%) 02/02/23 Apple options imply 3.5% move in share price post-earnings 01/30/23 Notable open interest changes for January 30th 01/26/23 Notable open interest changes for January 26th 01/24/23 Notable open interest changes for January 24th

Downgrade	First Foundation downgraded to Neutral from Overweight at Piper Sandler » 06:06 02/03/23 02/03 06:06 02/03/23 06:06 FFWM First Foundation $16.33 / +0.375 (+2.35%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options FFWM First Foundation $16.33 / +0.375 (+2.35%) 11/21/22 First Foundation announces CEO Scott Kavanaugh named president 11/08/22 First Foundation says president DePillo to leave, CFO Thompson named interim FFWM First Foundation $16.33 / +0.375 (+2.35%) 01/03/23 Stephens Castle Biosciences, Academy Sports on Stephens 'Best Ideas' list for 2023 10/26/22 DA Davidson First Foundation downgraded to Neutral from Buy at DA Davidson 07/27/22 B. Riley First Foundation price target raised to $23 from $21 at B. Riley 07/11/22 B. Riley First Foundation downgraded to Neutral from Buy at B. Riley FFWM First Foundation $16.33 / +0.375 (+2.35%) 01/26/23 First Foundation reports Q4 EPS 31c, consensus 31c 10/25/22 First Foundation reports Q3 EPS 51c, consensus 51c 02/07/23 Regional Banks Investor Trip FFWM First Foundation $16.33 / +0.375 (+2.35%) 09/21/22 Seventeen new option listings on September 21st
Earnings	Cigna sees FY23 adjusted EPS $24.60, consensus $24.84 » 06:06 02/03/23 02/03 06:06 02/03/23 06:06 CI Cigna $301.39 / -11.73 (-3.75%) Sees FY23 revenue at… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CI Cigna $301.39 / -11.73 (-3.75%) 02/02/23 Managed care stocks pressured after CMS' preliminary Medicare Advantage rates 01/12/23 California AG files suit against drugmakers, PBMs over insulin prices 12/06/22 Walmart to pay $500,000 over workers' compensation prescription procedures 11/07/22 WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD CI Cigna $301.39 / -11.73 (-3.75%) 01/31/23 JPMorgan Medicare Advantage final rule more favorable than feared, says JPMorgan 01/03/23 Wells Fargo Wells Fargo downgrades Cigna to Equal Weight, lowers price target to $355 01/03/23 Wells Fargo Cigna downgraded to Equal Weight from Overweight at Wells Fargo 11/23/22 Morgan Stanley Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley CI Cigna $301.39 / -11.73 (-3.75%) 06:02 Today Cigna reports Q4 adjusted EPS $4.96, consensus $4.86 02/02/23 Notable companies reporting before tomorrow's open 02/02/23 Notable companies reporting before tomorrow's open 11/03/22 Cigna raises FY22 adjusted EPS view to at least $23.10 from at least $22.90 CI Cigna $301.39 / -11.73 (-3.75%) 01/27/23 Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says 11/29/22 Managed care company returns will be tough to keep replicating, WSJ says 11/07/22 Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports 08/18/22 White House plans for end of COVID-19 vaccine coverage, WSJ reports CI Cigna $301.39 / -11.73 (-3.75%) 01/27/23 What You Missed On Wall Street This Morning 11/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/03/22 Fly Intel: Pre-market Movers 08:30 Today Cigna - CI CI Cigna $301.39 / -11.73 (-3.75%) 01/13/23 Early notable gainers among liquid option names on January 13th
Syndicate	Quoin Pharmaceuticals files to sell $10M of ordinary shares » 06:05 02/03/23 02/03 06:05 02/03/23 06:05 QNRX Quoin Pharmaceuticals $2.51 / +0.19 (+8.19%) Represented by American… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings QNRX Quoin Pharmaceuticals $2.51 / +0.19 (+8.19%) 12/13/22 Quoin announces dosing of first patient in trial in Netherton Syndrome 11/03/22 Quoin Pharmaceuticals announces updated Q3 conference call timing 10/18/22 Quoin announces plans to initiate second trial in Netherton syndrome patients 09/13/22 Quoin Pharmaceuticals establishes patient specific website for ongoing study QNRX Quoin Pharmaceuticals $2.51 / +0.19 (+8.19%) 09/07/22 Alliance Global Partners Quoin Pharmaceuticals initiated with a Buy at Alliance Global Partners 08/19/22 JMP Securities Quoin Pharmaceuticals price target lowered to $15 from $100 at JMP Securities 08/19/22 Maxim Quoin Pharmaceuticals price target lowered to $10 from $25 at Maxim 05/06/22 Ladenburg Ladenburg starts Quoin Pharmaceuticals at Buy with $2 price target QNRX Quoin Pharmaceuticals $2.51 / +0.19 (+8.19%) 11/10/22 Quoin Pharmaceuticals reports Q3 ADS (94c) vs ($5.84) last year 08/18/22 Quoin Pharmaceuticals reports Q2 EPS ($3.24) vs. ($18.05) last year
Downgrade	Hexcel downgraded to Neutral from Buy at BofA » 06:05 02/03/23 02/03 06:05 02/03/23 06:05 HXL Hexcel $71.23 / +0.03 (+0.04%) BofA analyst Ronald… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HXL Hexcel $71.23 / +0.03 (+0.04%) 10/25/22 Coinbase launches USDC institutional rewards program with MakerDAO 10/24/22 Hexcel did not repurchase any common stock during Q3 HXL Hexcel $71.23 / +0.03 (+0.04%) 01/30/23 Jefferies Hexcel price target raised to $70 from $60 at Jefferies 01/30/23 Wells Fargo Hexcel price target raised to $70 from $60 at Wells Fargo 01/27/23 Truist Hexcel price target raised to $59 from $53 at Truist 01/09/23 Truist Hexcel price target raised to $53 from $52 at Truist HXL Hexcel $71.23 / +0.03 (+0.04%) 01/25/23 Hexcel sees FY23 EPS $1.70-$1.90, consensus $1.82 01/25/23 Hexcel reports Q4 EPS 40c, consensus 32c 10/24/22 Hexcel narrows FY22 adjusted EPS view to $1.12-$1.24 from $1.00-$1.24 10/24/22 Hexcel reports Q3 adjusted EPS 33c, consensus 33c HXL Hexcel $71.23 / +0.03 (+0.04%) 01/25/23 Fly Intel: After-Hours Movers 02/15/23 44th Annual Aerospace/Defense & Industrials Conference
Downgrade	Camden Property downgraded on 'market drag' at Piper Sandler » 06:04 02/03/23 02/03 06:04 02/03/23 06:04 CPT Camden Property $126.29 / +2.55 (+2.06%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CPT Camden Property $126.29 / +2.55 (+2.06%) 10/10/22 Camden Property estimates $1.0M in expenses related to Hurricane Ian 09/30/22 Camden Property says early reports indicate minor damage from Hurricane Ian 09/30/22 Camden Property provides update on Hurricane Ian CPT Camden Property $126.29 / +2.55 (+2.06%) 02/02/23 Piper Sandler Camden Property downgraded to Neutral from Overweight at Piper Sandler 01/10/23 Mizuho Camden Property upgraded to Buy from Neutral at Mizuho 01/04/23 Deutsche Bank Camden Property price target lowered to $140 from $153 at Deutsche Bank 12/15/22 UBS Camden Property initiated with a Buy at UBS CPT Camden Property $126.29 / +2.55 (+2.06%) 02/02/23 Camden Property sees Q1 FFO $1.63-$1.67, consensus $1.75 02/02/23 Camden Property sees FY23 FFO $6.70-$7.00, consensus $7.17 02/02/23 Camden Property reports Q4 FFO $1.74, consensus $1.74 10/27/22 Camden Property see FY22 FFO $6.57-$6.61, consensus $6.63 08 Apr 03/08/23 Miami Property Tour 11:00 Today Camden Property - CPT
Downgrade	Ford downgraded to Sell from Hold at Deutsche Bank » 06:04 02/03/23 02/03 06:04 02/03/23 06:04 F Ford $14.34 / +0.535 (+3.88%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options F Ford $14.34 / +0.535 (+3.88%) 02/02/23 Ford sees FY23 capital expenditures $8B-$9B 02/02/23 Ford down 6% after Q4 earnings report 02/02/23 Ford declares regular Q1 dividend of 15c, supplemental dividend of 65c 02/02/23 Ford reports January U.S. sales up 2% to 146,356 vehicles F Ford $14.34 / +0.535 (+3.88%) 01/25/23 JPMorgan Ford price target lowered to $15 from $16 at JPMorgan 01/11/23 Goldman Sachs Goldman continues to prefer Tesla and GM among automakers 12/21/22 Morgan Stanley Tesla shedding $600B of value presents buying opportunity, says Morgan Stanley 12/05/22 Jefferies Fox Factory price target raised to $135 from $120 at Jefferies F Ford $14.34 / +0.535 (+3.88%) 02/02/23 Ford sees FY23 adjusted EBIT of $9B-$11B 02/02/23 Ford reports Q4 adjusted EPS 51c, consensus 62c 02/02/23 Notable companies reporting after market close 10/26/22 Ford reports Q3 adjusted EPS 39c, consensus 27c F Ford $14.34 / +0.535 (+3.88%) 02/02/23 Ford's Jan. U.S. sales increased 2% y/y, saw 'record' EV sales, Bloomberg says 01/24/23 Ford in discussions to sell German factory to BYD, WSJ reports 01/23/23 Union says Ford to slash up to 3,200 European jobs, Reuters reports 01/23/23 Ford planning massive layoffs overseas in favor of EV development, Electrek says F Ford $14.34 / +0.535 (+3.88%) 02/02/23 Fly Intel: After-Hours Movers 01/30/23 What You Missed On Wall Street On Monday 01/30/23 What You Missed On Wall Street This Morning 01/30/23 Here's what Wall St. experts are saying about these automakers ahead of earnings F Ford $14.34 / +0.535 (+3.88%) 02/02/23 Ford options imply 5.2% move in share price post-earnings 01/17/23 Ford put volume heavy and directionally bearish 12/30/22 Notable open interest changes for December 30th 12/19/22 Unusually active option classes on open December 19th
Initiation	Herbalife Nutrition initiated with an Underperform at BofA » 06:03 02/03/23 02/03 06:03 02/03/23 06:03 HLF Herbalife Nutrition $18.25 / -0.325 (-1.75%) BofA analyst Anna Liznul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options HLF Herbalife Nutrition $18.25 / -0.325 (-1.75%) 12/06/22 Herbalife Nutrition falls -19.5% 12/06/22 Herbalife Nutrition falls -16.6% 12/06/22 Herbalife Nutrition falls -15.0% 12/05/22 Herbalife Nutrition falls 10% to $15.70 after offering $250M in convertible debt HLF Herbalife Nutrition $18.25 / -0.325 (-1.75%) 11/01/22 B. Riley Herbalife Nutrition price target lowered to $31 from $38 at B. Riley 11/01/22 Citi Herbalife Nutrition price target lowered to $26 from $30 at Citi 10/05/22 Citi Herbalife Nutrition price target lowered to $30 from $36 at Citi 08/03/22 B. Riley Herbalife Nutrition price target lowered to $38 from $41 at B. Riley HLF Herbalife Nutrition $18.25 / -0.325 (-1.75%) 10/31/22 Herbalife Nutrition reports Q3 EPS 91c, consensus 74c HLF Herbalife Nutrition $18.25 / -0.325 (-1.75%) 12/06/22 What You Missed On Wall Street On Tuesday 12/06/22 What You Missed On Wall Street This Morning 12/06/22 Fly Intel: Pre-market Movers 12/05/22 Fly Intel: After-Hours Movers 03/21/23 6th Annual Consumer Growth Conference 02/14/23 Herbalife Nutrition - HLF HLF Herbalife Nutrition $18.25 / -0.325 (-1.75%) 12/23/22 Herbalife put volume heavy and directionally bearish 10/31/22 Herbalife options imply 8.4% move in share price post-earnings
Hot Stocks	Vyant Bio announces reduction in force and other measures to preserve cash » 06:03 02/03/23 02/03 06:03 02/03/23 06:03 VYNT Vyant Bio $1.02 / +0.0699 (+7.36%) Vyant Bio announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly VYNT Vyant Bio $1.02 / +0.0699 (+7.36%) 01/04/23 Vyant Bio engages LifeSci Capital to explore strategic alternatives 11/16/22 Vyant Bio regains compliance with Nasdaq minimum bid requirement 11/07/22 Vyant Bio teams up with IRSF to host local viewing party 11/03/22 Vyant Bio sells vivoPharm subsidiary to Reaction for $5.5M VYNT Vyant Bio $1.02 / +0.0699 (+7.36%) 10/04/22 Ascendiant Vyant Bio initiated with a Buy at Ascendiant VYNT Vyant Bio $1.02 / +0.0699 (+7.36%) 11/15/22 Vyant Bio reports Q3 EPS (59c) vs (77c) last year 08/22/22 Vyant Bio reports Q2 EPS (20c) vs (14c) last year VYNT Vyant Bio $1.02 / +0.0699 (+7.36%) 01/05/23 Fly Intel: Pre-market Movers
Recommendations	Alphabet price target raised to $155 from $130 at Oppenheimer » 06:02 02/03/23 02/03 06:02 02/03/23 06:02 GOOG Alphabet $108.77 / +7.375 (+7.27%) Oppenheimer analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 Alphabet says started bringing revenue sharing to YouTube Shorts 02/02/23 Alphabet reports Q4 Google Cloud revenue $7.3B vs. $5.54B last year 02/02/23 Alphabet taking actions to optimize global office space 02/01/23 'Tomb Raider Reloaded' coming to Google Play, iOS, Netflix on February 14 GOOG Alphabet $108.77 / +7.375 (+7.27%) 04:30 Today Piper Sandler Alphabet price target lowered to $120 from $122 at Piper Sandler 02/02/23 Morgan Stanley Meta Platforms price target raised to $190 from $130 at Morgan Stanley 01/31/23 BofA Alphabet price target raised to $119 at BofA ahead of earnings 01/30/23 KeyBanc Trade Desk price target lowered to $55 from $56 at KeyBanc GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 Alphabet reports Q4 EPS $1.05, consensus $1.18 02/02/23 Notable companies reporting after market close 10/25/22 Alphabet reports Q3 EPS $1.06, consensus $1.25 10/25/22 Notable companies reporting after market close GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 Democratic senator joins calls to ban TikTok, WSJ reports 02/01/23 GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports 02/01/23 Google testing ChatGPT-like products, including 'Apprentice Bard,' CNBC reports 01/31/23 Reels sharing revenue with creators hotly debated within Meta, Information says GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 What You Missed On Wall Street On Thursday 02/02/23 What You Missed On Wall Street This Morning 02/02/23 What Wall Street is saying about Alphabet ahead of earnings 02/01/23 #SocialStocks: Meta circumvents FTC challenge and will acquire Within Unlimited GOOG Alphabet $108.77 / +7.375 (+7.27%) 02/02/23 Alphabet options imply 5.9% move in share price post-earnings 01/20/23 Unusually active option classes on open January 20th 12/14/22 Alphabet put buyer realizes 126% same-day gains 11/02/22 Alphabet put buyer realizes 98% same-day gains
Earnings	Cigna reports Q4 adjusted EPS $4.96, consensus $4.86 » 06:02 02/03/23 02/03 06:02 02/03/23 06:02 CI Cigna $301.39 / -11.73 (-3.75%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CI Cigna $301.39 / -11.73 (-3.75%) 02/02/23 Managed care stocks pressured after CMS' preliminary Medicare Advantage rates 01/12/23 California AG files suit against drugmakers, PBMs over insulin prices 12/06/22 Walmart to pay $500,000 over workers' compensation prescription procedures 11/07/22 WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD CI Cigna $301.39 / -11.73 (-3.75%) 01/31/23 JPMorgan Medicare Advantage final rule more favorable than feared, says JPMorgan 01/03/23 Wells Fargo Wells Fargo downgrades Cigna to Equal Weight, lowers price target to $355 01/03/23 Wells Fargo Cigna downgraded to Equal Weight from Overweight at Wells Fargo 11/23/22 Morgan Stanley Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley CI Cigna $301.39 / -11.73 (-3.75%) 02/02/23 Notable companies reporting before tomorrow's open 02/02/23 Notable companies reporting before tomorrow's open 11/03/22 Cigna raises FY22 adjusted EPS view to at least $23.10 from at least $22.90 11/03/22 Cigna reports Q3 adjusted EPS $6.04, consensus $5.71 CI Cigna $301.39 / -11.73 (-3.75%) 01/27/23 Cigna sues CVS Health, Amy Bricker for violating noncompete, Bloomberg Law says 11/29/22 Managed care company returns will be tough to keep replicating, WSJ says 11/07/22 Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports 08/18/22 White House plans for end of COVID-19 vaccine coverage, WSJ reports CI Cigna $301.39 / -11.73 (-3.75%) 01/27/23 What You Missed On Wall Street This Morning 11/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/03/22 Fly Intel: Pre-market Movers 08:30 Today Cigna - CI CI Cigna $301.39 / -11.73 (-3.75%) 01/13/23 Early notable gainers among liquid option names on January 13th

Recommendations	Paylocity price target raised to $297 from $276 at Piper Sandler » 06:02 02/03/23 02/03 06:02 02/03/23 06:02 PCTY Paylocity $226.21 / +6.61 (+3.01%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events PCTY Paylocity $226.21 / +6.61 (+3.01%) 11/04/22 KeyBanc Paylocity price target lowered to $295 from $310 at KeyBanc 10/28/22 DA Davidson Paylocity cut to Neutral at DA Davidson on valuation, expectations for softer Q1 10/28/22 DA Davidson Paylocity downgraded to Neutral from Buy at DA Davidson 10/24/22 Needham Needham adds Five9 to Conviction List, removes Paylocity PCTY Paylocity $226.21 / +6.61 (+3.01%) 02/02/23 Paylocity sees FY23 revenue $1.156B-$1.161B, consensus $1.12B 02/02/23 Paylocity sees Q3 revenue $330.5M-$334.5M, consensus $318.65M 02/02/23 Paylocity reports Q2 non-GAAP EPS $1.12, consensus 73c 11/03/22 Paylocity sees Q2 revenue $257M-$261M, consensus $254.69M PCTY Paylocity $226.21 / +6.61 (+3.01%) 02/02/23 Fly Intel: After-Hours Movers 03/06/23 Technology Conference
Earnings	Johnson Outdoors reports Q1 EPS 57c vs. $1.07 a year ago » 06:02 02/03/23 02/03 06:02 02/03/23 06:02 JOUT Johnson Outdoors $71.37 / +2.04 (+2.94%) Reports Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events JOUT Johnson Outdoors $71.37 / +2.04 (+2.94%) 09/29/22 Johnson Outdoors raises quarterly cash dividend to 31c per share JOUT Johnson Outdoors $71.37 / +2.04 (+2.94%) 12/09/22 Johnson Outdoors reports Q4 EPS 95c vs. 68c a year ago 11:00 Today Johnson Outdoors - JOUT 03/01/23 Johnson Outdoors, Inc.
Downgrade	Direct Line Insurance downgraded to Underweight from Equal Weight at Barclays » 06:00 02/03/23 02/03 06:00 02/03/23 06:00 DIISY Direct Line Insurance $9.10 / +0.47 (+5.45%) Barclays analyst Ivan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research DIISY Direct Line Insurance $9.10 / +0.47 (+5.45%) 01/30/23 Berenberg Direct Line Insurance price target lowered to 159 GBp from 160 GBp at Berenberg 01/25/23 Berenberg Direct Line Insurance downgraded to Hold from Buy at Berenberg 01/24/23 UBS Direct Line Insurance price target lowered to 190 GBp from 194 GBp at UBS 01/24/23 Citi Direct Line Insurance downgraded to Sell from Neutral at Citi
Hot Stocks	Creative Media & Community Trust acquires three multifamily assets » 05:59 02/03/23 02/03 05:59 02/03/23 05:59 CMCT Creative Media & Community Trust $5.36 / -0.03 (-0.56%) CMCT announced that it is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CMCT Creative Media & Community Trust $5.36 / -0.03 (-0.56%) 08/15/22 CMCT signs long-term lease with O'Gara Coach for Beverly Hills showroom CMCT Creative Media & Community Trust $5.36 / -0.03 (-0.56%) 09/29/22 Edward Jones CIM Commercial Trust initiated with a Buy at Edward Jones
Recommendations	MAA price target raised to $190 from $180 at JMP Securities » 05:58 02/03/23 02/03 05:58 02/03/23 05:58 MAA MAA $173.90 / +5.49 (+3.26%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MAA MAA $173.90 / +5.49 (+3.26%) 12/13/22 MAA raises quarterly dividend 12% to $1.40 per share 10/19/22 MAA announces planned retirement of COO Thomas Grimes MAA MAA $173.90 / +5.49 (+3.26%) 01/17/23 Truist MAA downgraded to Hold from Buy at Truist 01/11/23 BTIG MAA price target lowered to $175 from $225 at BTIG 01/09/23 Credit Suisse MAA downgraded to Neutral from Outperform at Credit Suisse 01/03/23 Jefferies Independence Realty Trust downgraded at Jefferies on macro concerns MAA MAA $173.90 / +5.49 (+3.26%) 02/01/23 MAA sees Q1 core FFO $2.14-$2.30, consensus $2.25 02/01/23 MAA sees FY23 core FFO $8.88-$9.28, consensus $9.16 02/01/23 MAA reports Q4 core FFO $2.32, consensus $2.28 10/26/22 MAA sees Q4 core FFO $2.19-$2.35, consensus $2.20

Events

Earnings calls, analyst events, roadshows and more

AVTR
Today at 08:00

Avantor - AVTR Conference Calls
TWST
Today at 08:00

Twist Bioscience - TWST Conference Calls
SNY
Today at 08:00

Sanofi - SNY Conference Calls
Today at 08:30

Employment Situation: Average Hourly Earnings M/M: January 2023 Government Event
Today at 08:30

Employment Situation: Non-Farm Payrolls M/M: January 2023 Government Event
Today at 08:30

Employment Situation: Average Hourly Earnings Y/Y: January 2023 Government Event
Today at 08:30

Employment Situation--Unemployment Rate: January 2023 Government Event
Today at 08:30

Employment Situation: Average Workweek: January 2023 Government Event
Today at 08:30

Employment Situation: Private Payrolls M/M: January 2023 Government Event
Today at 08:30

Employment Situation: Manufacturing Payrolls M/M: January 2023 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	VERA X VERA Vera Therapeutics Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LIFC Priced at: $7.00 14.286M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ALGM X ALGM Allegro MicroSystems Block Trade Managers: Credit Suisse Priced at: $38.00 4.98M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GPCR X GPCR Structure Therapeutics IPO Managers: Jefferies, SVB Securities, Guggenheim & BMO Capital Priced at: $15.00 10.74M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ROIV X ROIV Roivant Sciences Secondary Managers: Goldman Sachs, SVB Securities, Cowen & Cantor Fitzgerald Priced at: $7.50 26.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AVTX X AVTX Avalo Therapeutics Spot Secondary Managers: SVB Securities & RBC Capital Priced at: $3.98 3.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CLLS X CLLS Cellectis Spot Secondary Managers: Jefferies & Barclays Priced at: $2.50 8.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDBL X EDBL Edible Garden Spot Secondary Managers: Maxim & Joseph Gunnar Priced at: $6.30 1.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	WULF X WULF TeraWulf Spot Secondary Managers: JonesResearch $1.03
Thurs	ASST X ASST Asset Entities IPO Managers: Boustead $5.00 1.5M Shares SODR X SODR Sondors IPO Managers: DA Davidson & Lake Street $8.00 - 10.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDXH X MDXH MDxHealth Secondary Managers: Cowen & William Blair, BTIG, KBCS $6.75 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TWO X TWO Two Harbors Spot Secondary Managers: Goldman Sachs, JPMorgan & Citi, JMP Securities $17.80-18.00 10M Shares
Fri	No deals

View All Syndicate Announcements »

NuCana regains compliance with Nasdaq minimum bid price requirement

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access